Thursday morning brought mixed signals for U.S. stock futures, with the Dow futures edging up around 0.1% while several notable names struggled in pre-market action.
Pre-Market Movers: Snowflake Slides Despite Earnings Beat While Symbotic Tumbles on Share Offering
Get ADC TELECOMMUNICATIONS Alerts
Weekly insights + SMS alerts
Snowflake's Puzzling Decline
The morning's head-scratcher comes from Snowflake Inc. (SNOW), which is getting hammered despite posting a solid earnings beat. The AI data cloud company delivered third-quarter revenue of $1.21 billion, topping analyst estimates of $1.18 billion. Adjusted earnings came in at 35 cents per share, beating expectations of 31 cents per share.
So why the sell-off? Sometimes beating estimates isn't enough if guidance disappoints or growth rates decelerate, though the market's reaction suggests investors found something less than thrilling in the details. Snowflake shares tumbled 8.6% to $241.85 in pre-market trading.
Other Notable Decliners
Net Lease Office Properties (NLOP) led the decliners, plunging 14.7% to $25.19 in pre-market action. That's a rough morning for the office property REIT.
Symbotic Inc. (SYM) dropped 10.5% to $65.50 after announcing a 10 million share offering. The warehouse automation company plans to sell 6.5 million new shares while a selling stockholder will offload another 3.5 million. Dilution fears are hitting the stock hard.
Capricor Therapeutics Inc. (CAPR) gave back some of Wednesday's massive gains, falling 8.4% to $27.45. This comes after the biotech rocketed 371% higher Wednesday on news that its Phase 3 HOPE-3 trial evaluating deramiocel cell therapy for Duchenne Muscular Dystrophy met its primary endpoint and secondary cardiac endpoint. A pullback after a move like that isn't exactly shocking.
ADC Therapeutics SA (ADCT) declined 8.1% to $3.63, extending Wednesday's 14% drop. The company recently reported updated data from its LOTIS-7 trial evaluating Zynlonta in combination with Glofitamab in relapsed/refractory DLBCL patients, and the market's reaction suggests the data didn't impress.
Rounding out the decliners: Lineage Cell Therapeutics Inc. (LCTX) fell 7.1% to $1.56, Koninklijke Philips NV (PHG) dropped 6.8% to $26.11, Omeros Corp. (OMER) declined 4.2% to $10.18, and Methanex Corp. (MEOH) slipped 3.8% to $35.95 in pre-market trading.
More News

The Fed's Favorite Inflation Gauge Just Hit a 3-Year High. Rate Hikes Are Back on the Table.

Your Book Attached

Micron Just Gave AI Investors Exactly What They Wanted

Iran Tightens the Screws on Strait of Hormuz Shipping, Threatens Action Against Unauthorized Transit

Futures Pop on Micron's AI Boost, Qualcomm's Big Bets, and Wendy's Meme Magic

Trump’s $100 Trillion “Gift” to Patriots?

NVIDIA Stock Gets a Boost from Micron's AI Earnings Blowout

Scott Bessent Defends Tariff Reboot, Unveils ‘3 Through 3’ Plan To Beat ‘Structural Inflation’
Get ADC TELECOMMUNICATIONS Alerts
Real-time alerts on price moves, news, and trading opportunities.
Join 20,000+ investors. No spam, ever.
Featured Articles
View all news
The Fed's Favorite Inflation Gauge Just Hit a 3-Year High. Rate Hikes Are Back on the Table.

Trump's Executive Order 14330: What Wall Street Doesn't Want You to Know (Ad)

Micron Just Gave AI Investors Exactly What They Wanted

Iran Tightens the Screws on Strait of Hormuz Shipping, Threatens Action Against Unauthorized Transit

Futures Pop on Micron's AI Boost, Qualcomm's Big Bets, and Wendy's Meme Magic

Strange Elon Crates Spotted Near the Hoover Dam (Ad)

NVIDIA Stock Gets a Boost from Micron's AI Earnings Blowout





